Does calorie restriction induce mitochondrial biogenesis
Given the huge unmet need and major health challenges, the negative trial results are very disappointing, and a sobering reminder that GLP-1 medicines will not be helpful for every medical condition, Daniel Drucker, an endocrinologist at the Lunenfeld-Tanenbaum Research Institute and a recent winner of the 2025 Breakthrough Prize in Life Sciences for his role in the development of GLP-1 agonists, told DDN
Clinical studies on pharmacological therapies for MC4R -deficient obesity Before reviewing individual pharmacological agents, it is essential to acknowledge the inherent limitations of the evidence supporting their use, specifically in MC4R -deficient obesity
Clinical Status: Thymalin is a research peptide evaluated in animal models and long-term observational studies, particularly within Eastern European gerontology research, for immune restoration and aging-related modulation
Body Protection Compound the most researched healing peptide